LENSAR, Inc.

NASDAQ:LNSR

11.25 (USD) • At close February 4, 2025
Bedrijfsnaam LENSAR, Inc.
Symbool LNSR
Munteenheid USD
Prijs 11.25
Beurswaarde 130,666,500
Dividendpercentage 0%
52-weken bereik 2.67 - 11.898
Industrie Medical Devices
Sector Healthcare
CEO Mr. Nicholas T. Curtis
Website https://www.lensar.com

An error occurred while fetching data.

Over LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual

Vergelijkbare Aandelen

eFFECTOR Therapeutics, Inc. logo

eFFECTOR Therapeutics, Inc.

EFTR

0 USD

Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd.

ENLV

1.08 USD

Synlogic, Inc. logo

Synlogic, Inc.

SYBX

1.32 USD

Longboard Pharmaceuticals, Inc. logo

Longboard Pharmaceuticals, Inc.

LBPH

59.98 USD

Homology Medicines, Inc. logo

Homology Medicines, Inc.

FIXX

0.935 USD

Eliem Therapeutics, Inc. logo

Eliem Therapeutics, Inc.

ELYM

5.11 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)